Califf: More Learning Necessary During Generic Drug Lifecycle
Executive Summary
The US FDA commissioner called for enhancements to postmarketing data collection and analysis for generic drugs.
You may also be interested in...
Good Clinical Practice Inspections Take On Narrower Focus During Pandemic, US FDA Says
Technological and logistical challenges have forced agency staff to triage document and interview requests to focus on the most important issues when conducting remote regulatory assessments and in-person inspections, an FDA official told a conference of international regulators.
Biden Requests US FDA Budget Surge: Pandemic Preparedness Money Would Increase Funding 36%
President Biden’s budget request would add $1.63bn in mandatory funding to the FDA budget in FY 2023.
US FDA Investigating Auto-Injector Problems With Copaxone Generics
Reports of bent needles and injector failures also raise questions about the FDA’s complex product approval process.